eli lilly glp 1 analog launches GLP-1 pill, kicking off showdown with Novo Nordisk Eli Lilly announces successful trial

In the 2026 ADA Scientific Sessions, results from the Phase-3 TRANSCEND-T2D-1 study involving retatrutide, a triple agonist of GLP-1, GIP, and glucagon receptors, showed up to a 2% decrease in A1C and a 16.8% decrease in body weight over 40 weeks in patients with type 2 diabetes

I recently had a baby so Im restarting my weight loss journey

Peptides help with chronic inflammation by calming inflammatory signals at their source, supporting tissue repair, and working alongside your body's natural healing processes rather than broadly suppressing them

Can the AI Nutritionist suggest higher-protein meal ideas when my appetite is low

When using phentermine you should also follow a diet and exercise program advised by your doctor